Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quality of medical products for diabetes management: a systematic review
Kartika Saraswati, Chanvilay Sichanh, Paul N. Newton, et al.
BMJ Global Health (2019) Vol. 4, Iss. 5, pp. e001636-e001636
Open Access | Times Cited: 25

Showing 25 citing articles:

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
Guillermo A Zabala, Khonsavath Bellingham, Vayouly Vidhamaly, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008587-e008587
Open Access | Times Cited: 46
A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality
Dominic McManus, Bernard Naughton
BMJ Global Health (2020) Vol. 5, Iss. 8, pp. e002393-e002393
Open Access | Times Cited: 59
A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
Jamee Ahmed, Laura Modica de Mohac, Tim K. Mackey, et al.
The Journal of Medicine Access (2022) Vol. 6
Open Access | Times Cited: 26
Hide and seek with falsified medicines: current challenges and physico-chemical and biological approaches for tracing the origin of trafficked products
Carla Perez-Mon, Cathrin Hauk, Alberto Roncone, et al.
Forensic Science International (2025) Vol. 370, pp. 112474-112474
Open Access
Patients Access to Medicines – A Critical Review of the Healthcare System in Kenya
Anthony Martin Toroitich, Louise Dunford, Rachel Armitage, et al.
Risk Management and Healthcare Policy (2022) Vol. Volume 15, pp. 361-374
Open Access | Times Cited: 16
Quality of Essential Medicines from Different Sources in Enugu and Anambra, Nigeria
Julia Gabel, Micha Lächele, Katharina Sander, et al.
American Journal of Tropical Medicine and Hygiene (2024) Vol. 111, Iss. 1, pp. 179-195
Open Access | Times Cited: 3
‘Prevalence, experience and awareness of substandard and falsified medicines among the public and healthcare professionals in Jordan’
Miftahul Falah, Eman Daar, Daniel Zahra, et al.
BMJ Global Health (2025) Vol. 10, Iss. 5, pp. e018189-e018189
Open Access
Comparison of several strategies for the deployment of a multivariate regression model on several handheld NIR instruments. Application to the quality control of medicines
Patient Hamuli Ciza, Pierre‐Yves Sacré, Christèlle Waffo, et al.
Journal of Pharmaceutical and Biomedical Analysis (2022) Vol. 215, pp. 114755-114755
Closed Access | Times Cited: 14
The quality of veterinary medicines and their implications for One Health
Vayouly Vidhamaly, Khonsavath Bellingham, Paul N. Newton, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008564-e008564
Open Access | Times Cited: 12
Quality assessment of medicines in selected resource-limited primary healthcare facilities using low- to medium-cost field testing digital technologies
Kwabena F.M. Opuni, Gifty Sunkwa-Mills, Maxwell Antwi, et al.
Digital Health (2024) Vol. 10
Open Access | Times Cited: 2
The quality of medical products for cardiovascular diseases: a gap in global cardiac care
Ngan Thi, Khonsavath Bellingham, Paul N. Newton, et al.
BMJ Global Health (2021) Vol. 6, Iss. 9, pp. e006523-e006523
Open Access | Times Cited: 14
The quality of antiretroviral medicines: an uncertain problem
Ngan Thi, Phonepasith Boupha, Paul N. Newton, et al.
BMJ Global Health (2023) Vol. 8, Iss. 3, pp. e011423-e011423
Open Access | Times Cited: 5
A study of the quality of cardiovascular and diabetes medicines in Malang District, Indonesia, using exposure-based sampling
Aksari Dewi, Anushka Patel, Anna Palagyi, et al.
BMJ Global Health (2022) Vol. 7, Iss. 11, pp. e009762-e009762
Open Access | Times Cited: 7
Ethnobotanical Study of Medicinal Plants used by Traditional Health Practitioners to Manage Diabetes Mellitus in Safi and Essaouira Provinces (Central-Western Morocco)
Adel Tahraoui, Jaouad El Hilaly, Youness El Achhab, et al.
Tropical Journal of Natural Product Research (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Variation in Price of Cardiovascular and Diabetes Medicine in Indonesia, and Relationship with Quality: A Mixed Methods Study in East Java
Elizabeth Pisani, Aksari Dewi, Anna Palagyi, et al.
American Journal of Tropical Medicine and Hygiene (2023)
Open Access | Times Cited: 4
Medicine Across Borders: Exploration of Grey Zones

(2023)
Open Access | Times Cited: 4
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
Elizabeth Pisani, Ayu Rahmawati, Esti Mulatsari, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 12, pp. e0003999-e0003999
Open Access | Times Cited: 1
Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
Ariadna Nebot Giralt, Anthony Bourasseau, Gareth White, et al.
BMJ Global Health (2020) Vol. 5, Iss. 10, pp. e003147-e003147
Open Access | Times Cited: 9
Medicine quality in high-income countries: The obstacles to comparative prevalence studies
Bernard Naughton, Erol Akgül
Medicine Access Point of Care (2021) Vol. 5
Open Access | Times Cited: 7
Review of drug recalls and quality of pharmaceutical products in Nepal
Astha Neupane, Maheshwor Bastakoti, Sabita Tamang, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e053479-e053479
Open Access | Times Cited: 5
A randomised survey of the quality of antibiotics and other essential medicines in Indonesia, with volume-adjusted estimates of the prevalence of substandard medicines
Elizabeth Pisani, Ayu Rahmawati, Esti Mulatsari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Suspected poor-quality medicines in Kenya: a retrospective descriptive study of medicine quality-related complaints reports in Kenya’s pharmacovigilance database
Anthony Martin Toroitich, Rachel Armitage, Sangeeta Tanna
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
Incidences of poor-quality pharmaceutical products in Nepal
Astha Neupane, Maheshwor Bastakoti, Sabita Tamang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
A study of the quality of cardiovascular and diabetes medicines in Malang District, Indonesia, using exposure-based sampling
Aksari Dewi, Anushka Patel, Anna Palagyi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Detecting falsified oral contraceptives by visual assessment and diffuse reflectance spectroscopy (350–2500 nm): the need for supplementing traditional pharmacopeia techniques and the public health implications
David W. Jenkins, Chérif Diallo, Michael Payne
Heliyon (2022) Vol. 8, Iss. 10, pp. e10837-e10837
Open Access | Times Cited: 1
Page 1

Scroll to top